Home › Steatotic Liver Disease › Florida
Pag-aaral pangklinika para sa Steatotic Liver Disease sa Florida
20 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
- Miami16 pag-aaral
- Orlando9 pag-aaral
- Hialeah9 pag-aaral
- Ocala8 pag-aaral
- Cape Coral6 pag-aaral
- Sarasota6 pag-aaral
- Jacksonville5 pag-aaral
- West Palm Beach5 pag-aaral
- Spring Hill4 pag-aaral
- Doral4 pag-aaral
- Brandon4 pag-aaral
- Homestead4 pag-aaral
- St. Petersburg3 pag-aaral
- Gainesville3 pag-aaral
- Deltona3 pag-aaral
- Boca Raton3 pag-aaral
- The Villages3 pag-aaral
- Kendall3 pag-aaral
- Lakeland3 pag-aaral
- Town 'n' Country3 pag-aaral
- Melbourne3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Ocala
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Ocala
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Health Awareness, Inc, Jupiter
- Evolution Clinical Trials, Miami
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of Miami Health System, Miami
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Evolution Clinical Trials, Hialeah Gardens
- Health Awareness, inc., Jupiter
- Genoma Research Group, Inc., Miami
- at 2 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- K2 Medical Research WINTER GARDEN, Clermont
- K2 Medical Research - Daytona Beach, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- at 20 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Bradenton
- Akero Clinical Study Site, Brandon
- Akero Clinical Study Site, Cutler Bay
- at 23 pa
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- at 19 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Synergy Healthcare, Bradenton
- Synergy Healthcare, Bradenton
- Health Awareness, Inc., Jupiter
- at 6 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Brandon
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- at 15 pa
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- 89bio Clinical Study Site, Gainesville
- at 15 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06419374Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- AdventHealth Translational Research Institute, Orlando
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 hanggang 55 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT06993454A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Brandon
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami Lakes
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- at 20 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Miami
- GSK Investigational Site, Viera
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Tampa
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT07358546A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Genoma Research Group, Inc, Miami
- Med Research of Florida, LLC, Miami
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT05648214Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Clinical Pharmacology of Miami, Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 14, 2025 · NCT07122700Low-Dose Pioglitazone in Patients With NASH (AIM 2)
- University of Florida, Gainesville
Nagre-recruitPhase 2
Edad 21 hanggang 75 · Lahat ng kasarian · Na-update Abr 4, 2025 · NCT04501406AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- AdventHealth Translational Research Institute, Orlando
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2025 · NCT04807868Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.